NCT05603052 A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older Status COMPLETED Phase PHASE3
NCT05602961 A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster Status WITHDRAWN Phase PHASE1/PHASE2
NCT05601167 Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population Status COMPLETED Phase PHASE3
NCT05599893 Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection. Status COMPLETED Phase NA
NCT05599529 A Retrospective Cohort Study of Differential Attainment, COVID-19 and Chaos Status COMPLETED Phase N/A
NCT05599516 Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial Status UNKNOWN Phase PHASE3
NCT05597761 Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05596734 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza Status COMPLETED Phase PHASE2
NCT05596032 Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2 Status COMPLETED Phase N/A
NCT05595837 Immune Registry for Organ Transplantation From COVID Positive Donors. Status COMPLETED Phase N/A
NCT05595824 Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19 Status COMPLETED Phase PHASE3
NCT05595538 Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19 Status COMPLETED Phase EARLY_PHASE1
NCT05594615 Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05594602 Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT05593770 International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response Status TERMINATED Phase PHASE2/PHASE3
NCT05593042 Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile Status COMPLETED Phase PHASE2